DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Monday reported a loss of $23.5 million in its second quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 27 cents.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The biopharmaceutical company posted revenue of $440,000 in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News